Bottom line
How much do SHSSX and TMED overlap?
47% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 35.4% of SHSSX's assets and 44.1% of TMED's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings SHSSX and TMED have in common
| Holding | % of SHSSX | % of TMED | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 12.29% | 16.71% | 12.29% |
| Unitedhealth Group Inc UNH | 6.10% | 6.52% | 6.10% |
| Gilead Sciences Inc GILD | 4.19% | 4.44% | 4.19% |
| Thermo Fisher Scientific Inc TMO | 3.02% | 4.11% | 3.02% |
| Pfizer Inc PFE | 2.61% | 1.91% | 1.91% |
| Danaher Corp DHR | 2.00% | 2.96% | 2.00% |
| Intuitive Surgical Inc ISRG | 1.95% | 2.43% | 1.95% |
| Biogen Inc BIIB | 1.21% | 1.55% | 1.21% |
| Stryker Corp SYK | 1.15% | 2.22% | 1.15% |
| Humana Inc HUM | 0.92% | 1.24% | 0.92% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SHSSX
- Johnson & Johnson — 8.77%
- Merck & Company Inc — 4.94%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Vertex Pharmaceuticals Inc — 2.74%
- Edwards Lifesciences Corp — 2.51%
- Abbott Laboratories — 1.97%
- Teva Pharmaceutical Industries Ltd — 1.87%
- Boston Scientific Corp — 1.59%
- Elevance Health Inc — 1.56%
- Argenx Se — 1.26%
- Astrazeneca Plc — 1.21%
- Blackrock Funds III — 1.01%
- Revolution Medicines Inc — 0.96%
- Regeneron Pharmaceuticals Inc — 0.91%
Only in TMED
- Cencora Inc — 2.75%
- Agilent Technologies Inc — 2.61%
- Alnylam Pharmaceuticals Inc — 2.60%
- Insulet Corp — 2.38%
- Dyne Therapeutics Inc — 2.03%
- Elanco Animal Health Inc — 1.91%
- Cytokinetics Inc — 1.69%
- Waters Corp — 1.68%
- West Pharmaceutical Services — 1.65%
- Ascendis Pharma A/s — 1.60%
- Mckesson Corp — 1.46%
- Dexcom Inc — 1.46%
- Immunome Inc — 1.38%
- Biontech Se-adr — 1.29%
- Denali Therapeutics Inc — 1.22%
Asset mix
| Asset type | SHSSX | TMED |
|---|---|---|
| Stocks | 99.8% | 99.3% |
| Cash & short-term funds | 1.4% | 0.7% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Country mix
| Country | SHSSX | TMED |
|---|---|---|
| US | 93.9% | 93.3% |
| IL | 1.9% | — |
| DK | — | 1.6% |
| DE | 0.1% | 1.6% |
| CH | 1.4% | 0.5% |
| GB | 1.4% | — |
| NL | 1.3% | 0.9% |
| KY | — | 1.1% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do SHSSX and TMED overlap?
What stocks do SHSSX and TMED have in common?
Should I own both SHSSX and TMED?
Which holds more stocks, SHSSX or TMED?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.